NasdaqGS:ILMNLife Sciences
Illumina (ILMN) Valuation Check After DRAGEN v4.5 Launch And Major Pediatric Genomics Partnership
Illumina (ILMN) is back in focus after the company rolled out DRAGEN v4.5, a major software update for genomic analysis, alongside a large pediatric data partnership that is drawing fresh attention to its core sequencing ecosystem.
See our latest analysis for Illumina.
The latest DRAGEN v4.5 launch and the large pediatric data partnership arrive as Illumina’s share price trades at US$134.50, with a 7 day share price return of 11.22% and a 1 year total shareholder return of 88.90%. However, 3...